Medtronic (MDT) Net Cash Flow (2014 - 2026)

Medtronic has disclosed Net Cash Flow across 13 years of filings, most recently posting -$159.0 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$159.0 million, down 562.5% year-over-year; the trailing twelve-month figure through Jan 2026 was -$428.0 million (down 88.55% YoY), and the FY2025 annual result was $746.0 million, up 2672.41% from the prior year.
• Net Cash Flow came in at -$159.0 million for Q1 2026 at Medtronic, down from $48.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.8 billion in Q4 2022 to a low of -$2.9 billion in Q2 2023.
• The 5-year median for Net Cash Flow is -$4.0 million (2024), against an average of -$107.5 million.
• Across the five-year window, Net Cash Flow soared 3036.84% in 2022 and tumbled 25200.0% in 2025, its largest moves.
• Medtronic's Net Cash Flow stood at $2.8 billion in 2022, then plunged by 94.73% to $147.0 million in 2023, then slumped by 46.26% to $79.0 million in 2024, then slumped by 39.24% to $48.0 million in 2025, then slumped by 431.25% to -$159.0 million in 2026.
• The last three Net Cash Flow figures came in at -$159.0 million (Q1 2026), $48.0 million (Q4 2025), and -$1.0 billion (Q3 2025), per Business Quant data.